Gabapentin for the Treatment of Vulvodynia: A Randomized Controlled Trial

OBJECTIVE:To evaluate whether extended-release gabapentin is more effective than placebo among women with vulvodynia.METHODS:In a multicenter double-blind, placebo-controlled randomized crossover trial, gabapentin (1,200–3,000 mg/d) was compared with a placebo. The primary outcome was mean pain inte